Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties

BACKGROUND: There is a need for improved antibiotic formulations for the treatment of acute bacterial skin and soft structure infection (ABSSSI), especially with the rise of antimicrobial resistance among Gram-positive bacteria. A new formulation of oritavancin was developed to reduce intravenous in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoover, Randall K, Krsak, Martin, Molina, Kyle C, Shah, Kairav, Redell, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982769/
https://www.ncbi.nlm.nih.gov/pubmed/35392455
http://dx.doi.org/10.1093/ofid/ofac090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982769/
https://www.ncbi.nlm.nih.gov/pubmed/35392455
http://dx.doi.org/10.1093/ofid/ofac090

Ejemplares similares